Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

Maria Coco, Heather Rush

Research output: Contribution to journalArticle

418 Citations (Scopus)

Abstract

To study the complications of renal osteodystrophy in patients with end-stage renal disease, we reviewed the incidence of hip fractures in our outpatient dialysis population from 1988 to 1998. One thousand two hundred seventy-two patients were treated for a total of 4,039 patient-years; 56 hip fractures were documented during this period. The incidence of hip fractures was many times greater in the dialysis patients than in the general population in each of the age-, race-, and sex-matched subgroups. The 1-year mortality rate from the hip fracture event was nearly two and a half times greater in the dialysis patients compared with the general population. The incidence of hip fractures in the first half of the decade was similar to that observed in the second half. When parathyroid hormone (PTH) levels were evaluated, we determined that patients with lower serum PTH revels were more likely to sustain a hip fracture than patients with higher PTH levels (P < 0.006). In addition, we determined that patients with lower PTH levels had an earlier mortality than patients with higher PTH levels (P < 0.03). We conclude that despite more aggressive therapy directed toward bone health in our dialysis patients in recent years, the incidence of hip fractures and their devastating morbidity and mortality remained unchanged over the past decade. Lower PTH levels may predispose to earlier mortality. (C) 2000 by the National Kidney Foundation, Inc.

Original languageEnglish (US)
Pages (from-to)1115-1121
Number of pages7
JournalAmerican Journal of Kidney Diseases
Volume36
Issue number6
StatePublished - 2000

Fingerprint

Hip Fractures
Parathyroid Hormone
Dialysis
Incidence
Serum
Mortality
Population
Chronic Kidney Disease-Mineral and Bone Disorder
Chronic Kidney Failure
Outpatients
Morbidity
Bone and Bones
Health

Keywords

  • Dialysis
  • Hip fracture
  • Parathyroid hormone (PTH)
  • Renal osteodystrophy

ASJC Scopus subject areas

  • Nephrology

Cite this

Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. / Coco, Maria; Rush, Heather.

In: American Journal of Kidney Diseases, Vol. 36, No. 6, 2000, p. 1115-1121.

Research output: Contribution to journalArticle

@article{587cc93fabb342e09a36c199d885a33f,
title = "Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone",
abstract = "To study the complications of renal osteodystrophy in patients with end-stage renal disease, we reviewed the incidence of hip fractures in our outpatient dialysis population from 1988 to 1998. One thousand two hundred seventy-two patients were treated for a total of 4,039 patient-years; 56 hip fractures were documented during this period. The incidence of hip fractures was many times greater in the dialysis patients than in the general population in each of the age-, race-, and sex-matched subgroups. The 1-year mortality rate from the hip fracture event was nearly two and a half times greater in the dialysis patients compared with the general population. The incidence of hip fractures in the first half of the decade was similar to that observed in the second half. When parathyroid hormone (PTH) levels were evaluated, we determined that patients with lower serum PTH revels were more likely to sustain a hip fracture than patients with higher PTH levels (P < 0.006). In addition, we determined that patients with lower PTH levels had an earlier mortality than patients with higher PTH levels (P < 0.03). We conclude that despite more aggressive therapy directed toward bone health in our dialysis patients in recent years, the incidence of hip fractures and their devastating morbidity and mortality remained unchanged over the past decade. Lower PTH levels may predispose to earlier mortality. (C) 2000 by the National Kidney Foundation, Inc.",
keywords = "Dialysis, Hip fracture, Parathyroid hormone (PTH), Renal osteodystrophy",
author = "Maria Coco and Heather Rush",
year = "2000",
language = "English (US)",
volume = "36",
pages = "1115--1121",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone

AU - Coco, Maria

AU - Rush, Heather

PY - 2000

Y1 - 2000

N2 - To study the complications of renal osteodystrophy in patients with end-stage renal disease, we reviewed the incidence of hip fractures in our outpatient dialysis population from 1988 to 1998. One thousand two hundred seventy-two patients were treated for a total of 4,039 patient-years; 56 hip fractures were documented during this period. The incidence of hip fractures was many times greater in the dialysis patients than in the general population in each of the age-, race-, and sex-matched subgroups. The 1-year mortality rate from the hip fracture event was nearly two and a half times greater in the dialysis patients compared with the general population. The incidence of hip fractures in the first half of the decade was similar to that observed in the second half. When parathyroid hormone (PTH) levels were evaluated, we determined that patients with lower serum PTH revels were more likely to sustain a hip fracture than patients with higher PTH levels (P < 0.006). In addition, we determined that patients with lower PTH levels had an earlier mortality than patients with higher PTH levels (P < 0.03). We conclude that despite more aggressive therapy directed toward bone health in our dialysis patients in recent years, the incidence of hip fractures and their devastating morbidity and mortality remained unchanged over the past decade. Lower PTH levels may predispose to earlier mortality. (C) 2000 by the National Kidney Foundation, Inc.

AB - To study the complications of renal osteodystrophy in patients with end-stage renal disease, we reviewed the incidence of hip fractures in our outpatient dialysis population from 1988 to 1998. One thousand two hundred seventy-two patients were treated for a total of 4,039 patient-years; 56 hip fractures were documented during this period. The incidence of hip fractures was many times greater in the dialysis patients than in the general population in each of the age-, race-, and sex-matched subgroups. The 1-year mortality rate from the hip fracture event was nearly two and a half times greater in the dialysis patients compared with the general population. The incidence of hip fractures in the first half of the decade was similar to that observed in the second half. When parathyroid hormone (PTH) levels were evaluated, we determined that patients with lower serum PTH revels were more likely to sustain a hip fracture than patients with higher PTH levels (P < 0.006). In addition, we determined that patients with lower PTH levels had an earlier mortality than patients with higher PTH levels (P < 0.03). We conclude that despite more aggressive therapy directed toward bone health in our dialysis patients in recent years, the incidence of hip fractures and their devastating morbidity and mortality remained unchanged over the past decade. Lower PTH levels may predispose to earlier mortality. (C) 2000 by the National Kidney Foundation, Inc.

KW - Dialysis

KW - Hip fracture

KW - Parathyroid hormone (PTH)

KW - Renal osteodystrophy

UR - http://www.scopus.com/inward/record.url?scp=0033659563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033659563&partnerID=8YFLogxK

M3 - Article

C2 - 11096034

AN - SCOPUS:0033659563

VL - 36

SP - 1115

EP - 1121

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 6

ER -